Skip to content

Liposomal Bupivacaine for Acute Pain Management Following Posterior Lumbar and Thoracic Decompression and Fusion Surgery in Adults: A Prospective, Randomized Controlled Trial

Bupivacaine liposome for acute pain management following posterior lumbar and thoracic decompression and fusion surgery in adults: A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105170
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative acute pain

Interventions

Experimental group:Local infiltration with liposomal bupivacaine and bupivacaine hydrochloride
Control group:Local infiltration with ropivacaine

Sponsors

Department of Anesthesiology, Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 18 and above; 2.American Society of Anesthesiologists physical status I to III; 3.Scheduled for 1- to 3-level posterior lumbar or thoracic decompression and fusion surgery due to degenerative spinal disease.

Exclusion criteria

Exclusion criteria: Pain or psychiatric disorders that may interfere with postoperative pain assessment; Allergy to any component of multimodal analgesia or local anesthesia; Acute phase of infection; Spinal metastatic malignancy; Pregnancy or lactation; Patient refusal or any other reason deemed by the investigator to make the patient unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Total opioid consumption within 72 hours postoperatively (morphine milligram equivalent, MME);

Secondary

MeasureTime frame
NRS at rest and with movement;use of intravenous PCA , such time to first patient-Initiated PCA dose;Sleep quality;Postoperative recovery: the first time to walk, eat, bowel movement, date of discharge, length of hospital stay.;Patient satisfaction;Opioid use in PACU ;

Countries

China

Contacts

Public ContactLi Min

Peking University Third Hospital

liminanesth@bjmu.edu.cn+86 135 2275 7239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026